Re: [68Ga]Ga-DATA5m.SA.FAPi PET/CT: Specific Tracer-uptake in Focal Nodular Hyperplasia and potential Role in Liver Tumor Imaging.
作者信息
Biersack Hans-Jürgen, Ahmadzadehfar H
机构信息
Department of Nuclear Medicine, University Hospital Bonn, Germany.
Department of Nuclear Medicine, Klinikum Westfalen, Dortmund, Germany.
出版信息
Nuklearmedizin. 2020 Dec;59(6):455. doi: 10.1055/a-1284-1920. Epub 2020 Dec 17.
PMID:33336350
Abstract
摘要
相似文献
1
Re: [68Ga]Ga-DATA5m.SA.FAPi PET/CT: Specific Tracer-uptake in Focal Nodular Hyperplasia and potential Role in Liver Tumor Imaging.回复：[68Ga]镓-DATA5m.SA.FAPi正电子发射断层显像/计算机断层扫描：局灶性结节性增生中特异性示踪剂摄取及其在肝脏肿瘤成像中的潜在作用
Nuklearmedizin. 2020 Dec;59(6):455. doi: 10.1055/a-1284-1920. Epub 2020 Dec 17.
2
[68Ga]Ga-DATA5m.SA.FAPi PET/CT: Specific Tracer-uptake in Focal Nodular Hyperplasia and potential Role in Liver Tumor Imaging.[68Ga]镓-DATA5m.SA.FAPi正电子发射断层显像/X线计算机体层成像：局灶性结节性增生中特异性示踪剂摄取及其在肝脏肿瘤成像中的潜在作用
Nuklearmedizin. 2020 Sep;59(5):387-389. doi: 10.1055/a-1164-5667. Epub 2020 May 11.
3
[In Reply: Invisible Hand - Re: [68Ga]Ga-DATA5m.SA.FAPi PET/CT: Specific Tracer-uptake in Focal Nodular Hyperplasia and potential Role in Liver Tumor Imaging].[回复：无形之手 - 关于：[68Ga]Ga - DATA5m.SA.FAPi PET/CT：局灶性结节性增生中的特异性示踪剂摄取及在肝脏肿瘤成像中的潜在作用]
Nuklearmedizin. 2020 Dec;59(6):456. doi: 10.1055/a-1288-7582. Epub 2020 Dec 17.
4
Increased [ Ga]Ga-FAPI uptake in focal nodular hyperplasia in a patient with sigmoid colon cancer.一名乙状结肠癌患者的局灶性结节性增生中[镓]镓-FAPI摄取增加。
Eur J Nucl Med Mol Imaging. 2021 Dec;49(1):415-416. doi: 10.1007/s00259-021-05519-5. Epub 2021 Aug 17.
5
Head-to-Head Comparison of [Ga]Ga-DOTA.SA.FAPi and [Ga]Ga-DOTANOC Positron Emission Tomography/Computed Tomography Imaging for the Follow-Up Surveillance of Patients with Medullary Thyroid Cancer.用于监测甲状腺髓样癌患者的[Ga]Ga-DOTA.SA.FAPi 和 [Ga]Ga-DOTANOC 正电子发射断层扫描/计算机断层扫描成像的头对头比较。
Thyroid. 2023 Aug;33(8):974-982. doi: 10.1089/thy.2023.0008. Epub 2023 Jun 1.
6
First Clinical Experience With [68Ga]Ga-FAPI-46-PET/CT Versus [18F]F-FDG PET/CT for Nodal Staging in Cervical Cancer.头颈部肿瘤 Ga-FAPI-46 PET/CT 与 18F-FDG PET/CT 对比用于淋巴结分期的初步临床经验
Clin Nucl Med. 2023 Feb 1;48(2):150-155. doi: 10.1097/RLU.0000000000004505.
7
Biodistribution, pharmacokinetics, dosimetry of [Ga]Ga-DOTA.SA.FAPi, and the head-to-head comparison with [F]F-FDG PET/CT in patients with various cancers.[Ga]Ga-DOTA.SA.FAPi 的生物分布、药代动力学、剂量学，以及与不同癌症患者的 [F]F-FDG PET/CT 的头对头比较。
Eur J Nucl Med Mol Imaging. 2021 Jun;48(6):1915-1931. doi: 10.1007/s00259-020-05132-y. Epub 2020 Nov 26.
8
Head-to-head comparison of [Ga]Ga-DOTA.SA.FAPi with [F]F-FDG PET/CT in radioiodine-resistant follicular-cell derived thyroid cancers.[Ga]Ga-DOTA.SA.FAPi 与 [F]F-FDG PET/CT 对头对头比较在放射性碘难治性滤泡细胞来源的甲状腺癌中的应用。
Eur J Nucl Med Mol Imaging. 2023 Dec;51(1):233-244. doi: 10.1007/s00259-023-06404-z. Epub 2023 Aug 29.
9
[F]FAPI-42 PET imaging in cancer patients: optimal acquisition time, biodistribution, and comparison with [Ga]Ga-FAPI-04.[F]FAPI-42 PET 成像在癌症患者中的应用：最佳采集时间、生物分布及与[Ga]Ga-FAPI-04 的比较。
Eur J Nucl Med Mol Imaging. 2022 Jul;49(8):2833-2843. doi: 10.1007/s00259-021-05646-z. Epub 2021 Dec 11.
10
A pilot study of [68Ga]Ga-fibroblast activation protein inhibitor-04 PET/CT in renal cell carcinoma.[68Ga]Ga-成纤维细胞激活蛋白抑制剂-04 PET/CT 在肾细胞癌中的初步研究。
Br J Radiol. 2024 Mar 28;97(1156):859-867. doi: 10.1093/bjr/tqae025.
Zotero 插件